tolbutamide has been researched along with Glycogen Storage Disease in 2 studies
Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.
Glycogen Storage Disease: A group of inherited metabolic disorders involving the enzymes responsible for the synthesis and degradation of glycogen. In some patients, prominent liver involvement is presented. In others, more generalized storage of glycogen occurs, sometimes with prominent cardiac involvement.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| LESTRADET, H | 1 |
| Colwell, JA | 1 |
| Wilber, JF | 1 |
2 other studies available for tolbutamide and Glycogen Storage Disease
| Article | Year |
|---|---|
[SECONDARY HEPATIC GLYCOGENOSIS].
Topics: Adolescent; Adrenocortical Hyperfunction; Carbohydrate Metabolism; Cataract; Child; Diabetes Mellitu | 1963 |
Studies of insulin and growth hormone secretion in a subject with hepatoma and gypoglycemia.
Topics: Adipose Tissue; Adult; Animals; Arginine; Blood Glucose; Carcinoma, Hepatocellular; Dexamethasone; F | 1971 |